Abstract 893: A novel approach to treating HER2-low breast cancer: surface-engineered NK/tz cells targeted immunotherapy
Year: 2025
Type: conference-abstract
Source: Cancer Research
Institution: University of Illinois Chicago
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4409690013
